In April and May 2026, the Company issued 1,259,320 shares of its common stock upon the exercise of options and warrants for proceeds of $126,000 at an exercise price of $0.10 per share. 

In April 2026, the Company issued 284,355 shares of its common stock upon the conversion of notes payable and accrued interest thereon at a conversion price of $0.08 to $0.15 per share.

In April 2026, the Company issued 750,000 shares of its common stock to its corporate secretary as compensation of $75,000 valued at $0.10. The Company also issued its corporate secretary options to purchase 1,000,000 shares of common stock to its corporate secretary as compensation. The options are exercisable at a price of $0.10, are fully vested, and expire three years from the date of grant.

In April 2026, the Company issued 3,450,000 shares of its common stock to consultants as compensation of $345,000 valued at $0.10 per share. The Company also issued the consultants options to purchase 3,900,000 shares of common stock as compensation. The options are exercisable at a price of $0.10 per share, are fully vested and expire three years from the date of grant.